Bayer AG today said its second-quarter sales jumped by 18 percent, boosted by revenues from new prescription medications and the over-the-counter consumer health products it acquired last year from Merck & Co., including the Coppertone and Claritin brands.
The Germany-based drug and chemicals giant said sales were 12.1 billion euros ($13.4 billion), and net income was 1.2 billion euros, up 21 percent from the second quarter of 2014.
Bayer’s material science segment, which makes plastics, chemicals and coatings, has its North American headquarters in Robinson. Bayer plans to spin off that business through a stock market flotation and it will operate under a new name, Covestro, beginning Sept. 1.
North American sales for Bayer MaterialScience in the second quarter were 766 million euros, up 18.6 percent from a year ago.
Joyce Gannon: jgannon@post-gazette.com or 412-263-1580.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.